The SP has settled at around 2 cents. Not sure we ca claim "resilience" as it is down from around 12 cents at the beginning of the year. Maybe the SP has just settled at a point where there is a comfort level balance between holders are prospective investors.
From MM herself, the final data is pretty much out, and she does not think it will change that much. I don't think that expecting any material change to the data can be reasonably anticipated.
One thing that I would like to see is how many participants in the HIV trial are showing any improvements after say 12 months. That would give a valid pointer as to how effective BIT225 was in fighting HIV. Maybe something to bring up at the AGM.
One potential avenue moving forward is whether BIT225 can be used in conjunction with other drugs in the HIV arena. Disappointing that BIT has not been approached by other companies in regard to joint trials - and maybe equally strange that BIT has not indicated that they are chasing this either. Again, something that could be interesting to bring up at the AGM.
BIT Price at posting:
1.9¢ Sentiment: Sell Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)